For patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not d ...

"Among dialysis patients with osteoporosis, denosumab may be more effective than oral bisphosphonates in reducing fracture ...

High and low blood eosinophil counts both predict the risk of all-cause and cardiac deaths in patients with acute myocardial ...

A heart attack, medically referred to as a myocardial infarction, occurs when the flow of blood to part of the heart muscle ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

Long-term use of SGLT2 inhibitors has been linked to various positive cardiovascular outcomes, including decreased rates of ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to ...

Costs related to cardiovascular health care represent a high burden and have been trending upward the past several years in ...